Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Dr. Igor Koralnik, chief of neuroinfectious diseases and global neurology, joins Marie Saavedra to talk about the findings.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...